Anebulo Pharmaceuticals, Inc. (ANEB)

NASDAQ: ANEB · IEX Real-Time Price · USD

2.790

+0.020 (0.72%)

At close: Apr 24, 2024, 3:35 PM

2.660

-0.130 (-4.66%)

After-hours: Apr 24, 2024, 4:00 PM EDT

Anebulo Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021
Net Income	-11.73	-6.83	-38.46
Share-Based Compensation	0.88	0.48	0.2
Other Operating Activities	1.16	0.91	25.18
Operating Cash Flow	-9.68	-5.44	-4.87
Share Issuance / Repurchase	6.38	0	22.03
Debt Issued / Paid	0	0	-0.2
Financing Cash Flow	6.38	0	21.83
Net Cash Flow	-3.3	-5.44	16.96
Free Cash Flow	-9.68	-5.44	-4.87
Free Cash Flow Per Share	-0.39	-0.23	-0.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).